FLT3-IN-10

CAS No. 2088735-51-5

FLT3-IN-10( 2-Oxazolamine, 5-(4-fluorophenyl)-N-phenyl-5-(4-fluorophenyl)-N-phenyl-1,3-oxazol-2-amine )

Catalog No. M28938 CAS No. 2088735-51-5

FLT3-IN-10 (compound 7c) is a potent inhibitor of FMS-like tyrosine kinase 3 (FLT3). FLT3-IN-10 shows the potential for the treatment of FLT3-mutated acute myeloid leukemia (AML).

Purity : >98% (HPLC)

COA Datasheet HNMR HPLC MSDS Handing Instructions
Size Price / USD Stock Quantity
1 mL x 10 mM in DMSO 49 In Stock
2MG 30 In Stock
5MG 51 In Stock
10MG 88 In Stock
25MG 181 In Stock
50MG 262 In Stock
100MG 373 In Stock
200MG 507 In Stock
500MG Get Quote In Stock
1G Get Quote In Stock

Biological Information

  • Product Name
    FLT3-IN-10
  • Note
    Research use only, not for human use.
  • Brief Description
    FLT3-IN-10 (compound 7c) is a potent inhibitor of FMS-like tyrosine kinase 3 (FLT3). FLT3-IN-10 shows the potential for the treatment of FLT3-mutated acute myeloid leukemia (AML).
  • Description
    FLT3-IN-10 (compound 7c) is a potent inhibitor of FMS-like tyrosine kinase 3 (FLT3). FLT3-IN-10 shows the potential for the treatment of FLT3-mutated acute myeloid leukemia (AML).
  • In Vitro
    ——
  • In Vivo
    ——
  • Synonyms
    2-Oxazolamine, 5-(4-fluorophenyl)-N-phenyl-5-(4-fluorophenyl)-N-phenyl-1,3-oxazol-2-amine
  • Pathway
    Angiogenesis
  • Target
    FLT
  • Recptor
    neuropeptide Y (NPY) Y1 receptor
  • Research Area
    ——
  • Indication
    ——

Chemical Information

  • CAS Number
    2088735-51-5
  • Formula Weight
    254.26
  • Molecular Formula
    C15H11FN2O
  • Purity
    >98% (HPLC)
  • Solubility
    In Vitro:?DMSO : 125 mg/mL (491.62 mM)
  • SMILES
    FC=1C=CC(=CC1)C=2OC(=NC2)NC=3C=CC=CC3
  • Chemical Name
    ——

Shipping & Storage Information

  • Storage
    (-20℃)
  • Shipping
    With Ice Pack
  • Stability
    ≥ 2 years

Reference

1.Antal-Zimanyi I, et al. Pharmacological characterization and appetite suppressive properties of BMS-193885, a novel and selective neuropeptide Y(1) receptor antagonist. Eur J Pharmacol. 2008 Aug 20;590(1-3):224-32.
molnova catalog
related products
  • AXL-IN-13

    AXL-IN-13 is a potent and orally active AXL inhibitor with an IC50 of 1.6 nM and a Kd of 0.26 nM.

  • Emavusertib

    Emavusertib is a potent IRAK4/FLT3 inhibtor. CA-4948 with anti-tumor activity.

  • 7BIO

    7-bromoindirubin-3'-oxime (7BIO) is a caspase independent nonapoptotic cell death inducer. 7BIO is an inhibitor of FLT3, DYRK1A, DYRK2, Aurora B and Aurora C kinases.